IHM
VNDA icon

Iguana Healthcare Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Iguana Healthcare Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-150,000
Closed -$1.69M – 82
2015
Q3 		$1.69M Buy
+150,000
New +$1.83M 0.67% 43
2014
Q4 		– Sell
-50,000
Closed -$519K – 72
2014
Q3 		$519K Sell
50,000
-50,000
-50% -$655K 0.28% 59
2014
Q2 		$1.62M Hold
100,000
– – 0.75% 47
2014
Q1 		$1.63M Buy
+100,000
New +$1.42M 0.75% 42

Other funds holding VNDA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iguana Healthcare Management's VNDA Position: Q4 2015 in Review

Iguana Healthcare Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2015, closing a stake of 150,000 shares — an estimated $1.69M sold.

Iguana Healthcare Management first reported a position in VNDA in Q1 2014 and held it in 4 quarters. The position peaked at $1.69M in Q3 2015. 117 funds tracked by Wall St. Rank hold VNDA as of Q4 2015.

  • Iguana Healthcare Management reported no remaining Vanda Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Iguana Healthcare Management sold 150,000 Vanda Pharmaceuticals shares in Q4 2015, an estimated $1.69M.
  • Iguana Healthcare Management first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Iguana Healthcare Management's Vanda Pharmaceuticals position peaked at $1.69M in Q3 2015.
  • 117 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2015.

Based on Iguana Healthcare Management's 13F filing for Q4 2015, filed 16 Feb 2016.